Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SBC vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SBC
SBC Medical Group Holdings Incorporated

Consulting Services

IndustrialsNASDAQ • US
Market Cap$330M
5Y Perf.-67.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+141.0%

SBC vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SBC logoSBC
ISRG logoISRG
IndustryConsulting ServicesMedical - Instruments & Supplies
Market Cap$330M$160.44B
Revenue (TTM)$178M$10.58B
Net Income (TTM)$43M$2.98B
Gross Margin73.7%66.3%
Operating Margin33.3%30.5%
Forward P/E7.1x43.7x
Total Debt$12M$303M
Cash & Equiv.$125M$3.37B

SBC vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SBC
ISRG
StockSep 22May 26Return
SBC Medical Group H… (SBC)10032.1-67.9%
Intuitive Surgical,… (ISRG)100241.0+141.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SBC vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SBC and ISRG are tied at the top with 3 categories each — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SBC
SBC Medical Group Holdings Incorporated
The Income Pick

SBC has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.

  • beta 0.76
  • Lower volatility, beta 0.76, Low D/E 6.3%, current ratio 3.01x
  • Beta 0.76, current ratio 3.01x
Best for: income & stability and sleep-well-at-night
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.6% 10Y total return vs SBC's -67.7%
  • 20.5% revenue growth vs SBC's 6.1%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs SBC's 6.1%
ValueSBC logoSBCLower P/E (7.1x vs 43.7x)
Quality / MarginsISRG logoISRG28.2% margin vs SBC's 24.3%
Stability / SafetySBC logoSBCBeta 0.76 vs ISRG's 1.02
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)SBC logoSBC+3.2% vs ISRG's -14.8%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs SBC's 13.5%, ROIC 15.0% vs 72.3%

SBC vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SBCSBC Medical Group Holdings Incorporated

Segment breakdown not available.

ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

SBC vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSBCLAGGINGISRG

Income & Cash Flow (Last 12 Months)

Evenly matched — SBC and ISRG each lead in 3 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 59.3x SBC's $178M. Profitability is closely matched — net margins range from 28.2% (ISRG) to 24.3% (SBC). On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$178M$10.6B
EBITDAEarnings before interest/tax$62M$3.8B
Net IncomeAfter-tax profit$43M$3.0B
Free Cash FlowCash after capex-$37M$2.8B
Gross MarginGross profit ÷ Revenue+73.7%+66.3%
Operating MarginEBIT ÷ Revenue+33.3%+30.5%
Net MarginNet income ÷ Revenue+24.3%+28.2%
FCF MarginFCF ÷ Revenue-20.5%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year-18.3%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+3.2%+18.8%
Evenly matched — SBC and ISRG each lead in 3 of 6 comparable metrics.

Valuation Metrics

SBC leads this category, winning 6 of 6 comparable metrics.

At 6.7x trailing earnings, SBC trades at a 88% valuation discount to ISRG's 57.4x P/E. On an enterprise value basis, SBC's 2.9x EV/EBITDA is more attractive than ISRG's 43.4x.

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
Market CapShares × price$330M$160.4B
Enterprise ValueMkt cap + debt − cash$217M$157.4B
Trailing P/EPrice ÷ TTM EPS6.67x57.40x
Forward P/EPrice ÷ next-FY EPS est.7.09x43.67x
PEG RatioP/E ÷ EPS growth rate2.64x
EV / EBITDAEnterprise value multiple2.93x43.44x
Price / SalesMarket cap ÷ Revenue1.61x15.94x
Price / BookPrice ÷ Book value/share1.59x9.13x
Price / FCFMarket cap ÷ FCF19.23x64.42x
SBC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

SBC leads this category, winning 5 of 8 comparable metrics.

SBC delivers a 17.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $17 for ISRG. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBC's 0.06x. On the Piotroski fundamental quality scale (0–9), SBC scores 7/9 vs ISRG's 6/9, reflecting strong financial health.

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+17.5%+16.9%
ROA (TTM)Return on assets+13.5%+14.8%
ROICReturn on invested capital+72.3%+15.0%
ROCEReturn on capital employed+37.9%+16.5%
Piotroski ScoreFundamental quality 0–976
Debt / EquityFinancial leverage0.06x0.02x
Net DebtTotal debt minus cash-$113M-$3.1B
Cash & Equiv.Liquid assets$125M$3.4B
Total DebtShort + long-term debt$12M$303M
Interest CoverageEBIT ÷ Interest expense596.05x
SBC leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $3,233 for SBC. Over the past 12 months, SBC leads with a +3.2% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs SBC's -32.2% — a key indicator of consistent wealth creation.

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-25.6%-19.6%
1-Year ReturnPast 12 months+3.2%-14.8%
3-Year ReturnCumulative with dividends-68.8%+49.0%
5-Year ReturnCumulative with dividends-67.7%+60.9%
10-Year ReturnCumulative with dividends-67.7%+556.9%
CAGR (3Y)Annualised 3-year return-32.2%+14.2%
ISRG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SBC and ISRG each lead in 1 of 2 comparable metrics.

SBC is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than ISRG's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 74.8% from its 52-week high vs SBC's 56.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5000.76x1.02x
52-Week HighHighest price in past year$5.75$603.88
52-Week LowLowest price in past year$2.97$427.84
% of 52W HighCurrent price vs 52-week peak+56.0%+74.8%
RSI (14)Momentum oscillator 0–10028.742.2
Avg Volume (50D)Average daily shares traded87K1.8M
Evenly matched — SBC and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SBC as "Buy" and ISRG as "Buy". Consensus price targets imply 179.5% upside for SBC (target: $9) vs 37.8% for ISRG (target: $623).

MetricSBC logoSBCSBC Medical Group…ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$9.00$622.60
# AnalystsCovering analysts155
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

SBC leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ISRG leads in 1 (Total Returns). 2 tied.

Best OverallSBC Medical Group Holdings … (SBC)Leads 2 of 6 categories
Loading custom metrics...

SBC vs ISRG: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is SBC or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 6. 1% for SBC Medical Group Holdings Incorporated (SBC). SBC Medical Group Holdings Incorporated (SBC) offers the better valuation at 6. 7x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate SBC Medical Group Holdings Incorporated (SBC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SBC or ISRG?

On trailing P/E, SBC Medical Group Holdings Incorporated (SBC) is the cheapest at 6.

7x versus Intuitive Surgical, Inc. at 57. 4x. On forward P/E, SBC Medical Group Holdings Incorporated is actually cheaper at 7. 1x.

03

Which is the better long-term investment — SBC or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +60. 9%, compared to -67. 7% for SBC Medical Group Holdings Incorporated (SBC). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus SBC's -67. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SBC or ISRG?

By beta (market sensitivity over 5 years), SBC Medical Group Holdings Incorporated (SBC) is the lower-risk stock at 0.

76β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 34% more volatile than SBC relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 6% for SBC Medical Group Holdings Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — SBC or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 6. 1% for SBC Medical Group Holdings Incorporated (SBC). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to 15. 5% for SBC Medical Group Holdings Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SBC or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 22. 7% for SBC Medical Group Holdings Incorporated — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBC leads at 34. 2% versus 29. 3% for ISRG. At the gross margin level — before operating expenses — SBC leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SBC or ISRG more undervalued right now?

On forward earnings alone, SBC Medical Group Holdings Incorporated (SBC) trades at 7.

1x forward P/E versus 43. 7x for Intuitive Surgical, Inc. — 36. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SBC: 179. 5% to $9. 00.

08

Which pays a better dividend — SBC or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is SBC or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Both have compounded well over 10 years (ISRG: +556. 9%, SBC: -67. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SBC and ISRG?

These companies operate in different sectors (SBC (Industrials) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SBC is a small-cap deep-value stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SBC

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 14%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SBC and ISRG on the metrics below

Revenue Growth>
%
(SBC: -18.3% · ISRG: 23.0%)
Net Margin>
%
(SBC: 24.3% · ISRG: 28.2%)
P/E Ratio<
x
(SBC: 6.7x · ISRG: 57.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.